| Ashley Lisiewski, DO | |
|
7800 Sheridan St, Pembroke Pines, FL 33024-2536 | |
| (954) 883-8855 | |
| Not Available |
| Full Name | Ashley Lisiewski |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 7800 Sheridan St, Pembroke Pines, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154764611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | UO2828 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Pembroke | Pembroke pines, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inphynet South Broward Llc | 4587563960 | 47 |
News Archive
Researchers have identified a drug that targets the first step in the toxic chain reaction leading to the death of brain cells, suggesting that treatments could be developed to protect against Alzheimer's disease, in a similar way to how statins are able to reduce the risk of developing heart disease.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Driving convertible cars with the top open at speeds exceeding 88.5 kilometres per hour may put drivers at increased risk of noise-induced hearing loss, according to new research published in The Journal of Laryngology and Otology, by Cambridge University Press on behalf of JLO Ltd from the Saint Louis University School of Medicine, Missouri and The Ear Institute of Texas, San Antonio.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
› Verified 9 days ago
| Entity Name | Inphynet South Broward Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871521880 PECOS PAC ID: 4587563960 Enrollment ID: O20040108000083 |
News Archive
Researchers have identified a drug that targets the first step in the toxic chain reaction leading to the death of brain cells, suggesting that treatments could be developed to protect against Alzheimer's disease, in a similar way to how statins are able to reduce the risk of developing heart disease.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Driving convertible cars with the top open at speeds exceeding 88.5 kilometres per hour may put drivers at increased risk of noise-induced hearing loss, according to new research published in The Journal of Laryngology and Otology, by Cambridge University Press on behalf of JLO Ltd from the Saint Louis University School of Medicine, Missouri and The Ear Institute of Texas, San Antonio.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Lisiewski, DO 3810 Ne 167th St, North Miami Beach, FL 33160-3539 Ph: () - | Ashley Lisiewski, DO 7800 Sheridan St, Pembroke Pines, FL 33024-2536 Ph: (954) 883-8855 |
News Archive
Researchers have identified a drug that targets the first step in the toxic chain reaction leading to the death of brain cells, suggesting that treatments could be developed to protect against Alzheimer's disease, in a similar way to how statins are able to reduce the risk of developing heart disease.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced positive results from its Phase 2 clinical study evaluating luliconazole, one of the most potent and broad spectrum topical antifungal agents, in patients with tinea pedis (athlete's foot). The study was designed to assess the effectiveness of 1% luliconazole cream applied once daily for 14 days compared with once daily for 28 days.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Driving convertible cars with the top open at speeds exceeding 88.5 kilometres per hour may put drivers at increased risk of noise-induced hearing loss, according to new research published in The Journal of Laryngology and Otology, by Cambridge University Press on behalf of JLO Ltd from the Saint Louis University School of Medicine, Missouri and The Ear Institute of Texas, San Antonio.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
› Verified 9 days ago
Dr. Christopher D Poe, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 N Flamingo Rd, Pembroke Pines, FL 33028 Phone: 954-436-5000 | |
Dr. Philip C Weimer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7800 Sheridan St, Pembroke Pines, FL 33024 Phone: 954-893-8014 Fax: 954-986-8306 | |
Dr. Joseph P. Bowers, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 703 N Flamingo Rd, Pembroke Pines, FL 33028 Phone: 954-436-5000 | |
Dr. Norville C Atherley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 801 S Douglas Rd, Pembroke Pines, FL 33025 Phone: 954-985-1470 | |
Dr. Jose R Garrote, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 703 N Flamingo Rd, Pembroke Pines, FL 33028 Phone: 954-436-5000 | |
Dr. Joseph P. Araiza, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 7800 Sheridan St, Pembroke Pines, FL 33024 Phone: 954-962-9650 |